Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5113229

Cc1ccc(-c2cccc(F)c2)c(NC(=O)O)c1.O=C(O)C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDH2 P48735 1/20 0.44
CHRM3 P20309 10/20 0.43
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
ALOX15 P16050 1/20 0.40
NFKB1 P19838 1/20 0.40
CASP1 P29466 1/20 0.40
CASP3 P42574 1/20 0.40
RAB9A P51151 1/20 0.40
NFKB2 Q00653 1/20 0.40
KMT2A Q03164 1/20 0.40
RELA Q04206 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
CHIT1 Q13231 1/20 0.39
TOP2A P11388 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5099269 0.91 AKR1C3 (0.44) IDH2MEN1NPC1KMT2AAKR1C3
Trifluoroacetic Acid SCHEMBL5099508 0.91 IDH2 (0.46) IDH2CHRM3MAPTTOP2AGRM5
Trifluoroacetic Acid SCHEMBL5113725 0.90 CHRM3 (0.52) CHRM3TOP2A
Trifluoroacetic Acid SCHEMBL5107022 0.90 AKR1C3 (0.44) IDH2CHRM3MEN1KMT2AAKR1C3
Trifluoroacetic Acid SCHEMBL5107023 0.86 IDH2 (0.45) IDH2MEN1KMT2A
Trifluoroacetic Acid SCHEMBL5103314 0.86 IDH2 (0.44) IDH2CHRM3MEN1RAB9AKMT2A
Trifluoroacetic Acid SCHEMBL5113759 0.85 KCNMA1 (0.45) IDH2MEN1NPC1MAPTRAB9A
SCHEMBL5113235 0.84 CHRM3 (0.45) IDH2CHRM3
Trifluoroacetic Acid SCHEMBL5103243 0.84 AKR1C3 (0.44) IDH2MEN1NPC1MAPTRAB9A
SCHEMBL16438521 0.83 CHRM3 (0.49) IDH2CHRM3NPC1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080249127-A1 Muscarinic Acetylcholine Receptor Antagonists LAINE DRAMANE I 2008-10-09 US claimed
US-20080249127-A1 Muscarinic Acetylcholine Receptor Antagonists LAINE DRAMANE I 2008-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249127-A1 Muscarinic Acetylcholine Receptor Antagonists CHRM3, CHRNG, CHRM2 IDH2 4016/4885CHRM3 1/4885MEN1 4053/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.